HomeMedicines › Glycomet-GP 2 Tablet PR

Glycomet-GP 2 Tablet PR

Glimepiride (2mg)

MRP (typical)
₹145.14 – ₹196.36
GST rate
5.0%
HSN
3004
Schedule
General
Pack
strip of 15 Tablet pr
Manufacturer
USV Ltd

About Glycomet-GP 2 Tablet PR

Glycomet-GP 2 Tablet PR contains Glimepiride 2mg, which belongs to the sulfonylurea class of antidiabetic medications. This controlled-release formulation is classified as a General schedule medicine in India. Glimepiride is commonly available in strengths ranging from 1mg to 4mg. As a pharmaceutical product, it attracts 5% GST under HSN code 3004. The medicine comes in a strip packaging of 15 prolonged-release tablets.

Substitutes and alternatives

The following medicines contain the same active ingredient (Glimepiride (2mg)) and may be offered by pharmacists as substitutes. Actual substitute selection depends on availability at your pharmacy and prescribing doctor's instructions.

Frequently asked

What is the GST rate and HSN code for Glycomet-GP 2 Tablet PR?

Glycomet-GP 2 Tablet PR attracts 5% GST as per Indian tax regulations and falls under HSN code 3004, which covers medicaments for therapeutic or prophylactic uses.

What is the schedule classification of this medicine?

Glycomet-GP 2 Tablet PR is classified as a General schedule medicine under Indian pharmaceutical regulations, meaning it can be sold without a prescription requirement.

What are common brand variants of Glimepiride 2mg in India?

Common brands containing Glimepiride 2mg in the Indian market may include Amaryl, Glimpid, Glimy, Glimser, and various generic formulations from different pharmaceutical manufacturers.

Selling Glycomet-GP 2 Tablet PR at your pharmacy?

Nesayo tracks your stock, flags near-expiry, and auto-orders from your distributor when you run low.

Start free →

This page is informational only. Pricing and availability vary by pharmacy, location, and time. Verify current MRP on the printed package before sale. Consult a registered physician or pharmacist for medical advice. Nesayo is not a medical device and does not provide clinical decision support.